Horizon
Biotechnology ResearchDublin, Ireland1001-5000 Employees
Horizon Therapeutics is now part of Amgen. The Horizon LinkedIn page is no longer active or monitored.
Market Expansion Horizon's recent engagement in seismic data marketing and strategic shifts suggest an openness to new technological solutions and partnerships, providing opportunities for sales teams to offer advanced data analytics, GIS tools, or cloud infrastructure enhancements.
Strategic Acquisition The acquisition by First Brands Group and related corporate activities indicate ongoing growth and integration, opening avenues to supply enterprise software, supply chain management systems, or operational automation tools to support their expanded operations.
Financial Repositioning With revenue figures between 100 million to 250 million and recent corporate restructuring, there is potential to present financial management solutions, SaaS offerings, or investment analytics tailored to their evolving financial landscape.
Industry Engagement As part of the biotechnology research industry within Dublin, Ireland, Horizon may be seeking collaborations in cloud computing, data security, or specialized biotech software, presenting targeted sales opportunities in these high-demand technology areas.
Technology Stack Utilizing platforms such as AWS, Salesforce, and ThoughtSpot suggests a focus on cloud-based data management and analytics; sales prospects include enterprise SaaS, CRM enhancements, and business intelligence solutions tailored to optimize their existing infrastructure.
Horizon uses 8 technology products and services including Salesforce Lightning, AWS Glue, ThoughtSpot, and more. Explore Horizon's tech stack below.
| Horizon Email Formats | Percentage |
| FLast@horizontherapeutics.com | 90% |
| FirstLast@horizontherapeutics.com | 5% |
| FirLast@horizontherapeutics.com | 1% |
| First.Last@horizontherapeutics.com | 1% |
| First@horizontherapeutics.com | 1% |
| FiLast@horizontherapeutics.com | 1% |
| LastF@horizontherapeutics.com | 1% |
| First.Last@amgen.com | 47% |
| FLast@amgen.com | 44% |
| FirstL@amgen.com | 7% |
| LastF@amgen.com | 2% |
Biotechnology ResearchDublin, Ireland1001-5000 Employees
Horizon Therapeutics is now part of Amgen. The Horizon LinkedIn page is no longer active or monitored.
Horizon's revenue is estimated to be in the range of $100M$250M
Horizon's revenue is estimated to be in the range of $100M$250M